LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Stoelzle – 15th May 2025

ACG Capsules introduces ACGcaps™ H+ a new line of Clean Label, Inert and Robust HPMC Capsules

ACG Capsules (ACGC) – part of ACG Group, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry – has introduced a new line of HPMC capsules meeting a wide variety of pharmaceutical and nutraceutical needs. The new ACGcaps™ H+ capsule with no gelling agent is suitable for hygroscopic and moisture-sensitive formulations. It also meets consumer demands for clean label and vegetarian capsule options. 

ACGcaps™ H+ Capsule complies with requirements of dissolution performance across all biological pH range since it is pH-independent and non-ionic. These capsules also reduce cross-linking problems which occur with gelatin base capsules resulting in retarded dissolution performance. 

ACGcaps™ H+ capsules are suitable for filling granules, powders, pellets for prescription and non-prescription pharmaceutical ingredients, nutraceutical dietary supplements and traditional medicines. 

“The new and enhanced range of HPMC capsules are designed to give pharma and nutraceutical customers added peace of mind by providing product protection and desired formulation release. The new line contains no gelatin, wheat, gluten, animal by-products or starch, making them ideal for supporting clean label claims and vegetarian diets.”, said Selwyn Noronha, CEO for ACG Capsules.

Scott Pharma – 25.03.2025
Bespak – 21.05.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025
Drug Discovery 2025, ELRIG – 04.07.2025